Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
As one of the main pharmacologically active phytocannabinoids of Cannabis and hemp plants, cannabidiol
(CBD) is non-psychoactive but exerts pharmacological effects in alleviating chronic pain. The anti-inflammatory and antioxidant properties make CBD particularly useful for skin disorders such as eczema and dermatitis. However, CBD is lipophilic and only soluble in oil, making it difficult to be added in aqueous formulations. The overall goal of this research between the University of Alberta and PBG BioPharma is to develop an edible CBD microencapsulation technology. We will then study the efficiency of the microencapsulations to load and protect CBD. The optimized microcapsules will be evaluated in food and cosmetic formulations and scale up at the pilot level. Achieving the research objectives will lead to a plant protein-based microencapsulation platform to unlock the full potentials of CBD for food and cosmetic applications.
Lingyun Chen
PBG BioPharma
Life Sciences
Manufacturing
University of Alberta
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.
Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.